文献速递心外重症与机械循环支持先天性心脏病外科

需透析的肾功能不全患儿置入心室辅助装置的结局:ACTION登记分析

Outcomes of ventricular assist device placement in pediatric patients with renal dysfunction requiring dialysis: an ACTION registry analysis.
PubMed 文献 · Ann Thorac Surg · 2026-09-17

基于ACTION登记中1607例儿童心室辅助装置(VAD)置入患者,75例(4.7%)术前需肾脏替代治疗(RRT)。RRT组临床状态更差、心脏移植率更低(44.0% vs 61.4%,p<0.001)、一年生存率更低(58.4% vs 78.3%,p<0.001),但多变量Cox分析显示RRT并非一年死亡风险的独立相关因素(HR 1.31,95%CI 0.81-2.10,p=0.273)。

要点

  • 儿童VAD置入术前需RRT者占4.7%,临床状态更差且一年生存率更低。
  • RRT组心脏移植率显著低于非RRT组(44.0% vs 61.4%)。
  • 校正后RRT并非一年死亡独立危险因素,提示基础疾病严重度驱动结局。

核心结论

  • 儿童VAD置入术前需RRT者罕见,虽临床状态更差、死亡率更高,但RRT并非一年死亡风险的独立相关因素,结局可能由基础疾病严重度驱动。

研究设计与样本

  • ACTION登记(57个北美中心,2018年4月至2025年6月)回顾性分析1607例儿童VAD置入患者,按手术时是否使用RRT分层。

主要发现

  • 1607例中75例(4.7%)手术时需RRT。
  • RRT组ECMO支持比例更高、INTERMACS分级更高、总胆红素更高。
  • RRT组心脏移植率更低:33/75(44.0%)vs 941/1532(61.4%),p<0.001。
  • RRT组一年生存率更低:58.4% vs 78.3%,p<0.001。
  • 多变量Cox分析中RRT与一年死亡风险无独立关联:HR 1.31,95%CI 0.81-2.10,p=0.273。

临床怎么用

  • 对需RRT的儿童VAD候选者,应综合评估基础疾病严重度而非仅因RRT拒绝VAD。
  • 术前需RRT的患儿VAD术后需密切监测死亡和移植等待风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal dysfunction requiring renal replacement therapy (RRT) is associated with poor outcomes following ventricular assist device (VAD) implantation in adults. However, outcomes in pediatric patients are not well-described. We aim to characterize pediatric patients supported by RRT who undergo VAD implantation and assess their short- and long-term outcomes. METHODS: The Advanced Cardiac Therapies Improving Outcomes Network (ACTION) Registry contains pre- and post-operative data on pediatric VAD patients across 57 North American sites (April 2018-June 2025). Patients were stratified by RRT use at surgery, including chronic dialysis and newly initiated RRT. Patient characteristics, pre-operative data, and clinical outcomes including one-year post-VAD survival, likelihood of transplant, and post-transplant survival were assessed using Kaplan-Meier survival, multivariable Cox proportional hazards models, and competing risk analysis. RESULTS: Of 1,607 patients undergoing VAD implantation, 75 (4.7%) were supported by RRT at surgery. These patients had worse clinical status, including a higher incidence of ECMO support, higher INTERMACS classification, and higher total bilirubin. RRT patients were less likely to undergo heart transplant (33/75 [44.0%] vs 941/1,532 [61.4%], p<0.001) and had higher mortality rates post-implant. Kaplan-Meier survival analysis revealed lower one-year survival in RRT patients (58.4% vs. 78.3%, p<0.001). However, in multivariable Cox analysis, RRT was not independently associated with one-year mortality risk (HR 1.31, 95% CI 0.81-2.10, p=0.273). CONCLUSIONS: Renal dysfunction requiring RRT is rare in children undergoing VAD placement. While these patients demonstrate worse clinical status and higher mortality, RRT is not independently associated with mortality risk, suggesting the underlying illness severity drives outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Catalano MA, Edelson JB, Amdani S, et al. Outcomes of ventricular assist device placement in pediatric patients with renal dysfunction requiring dialysis: an ACTION registry analysis. Ann Thorac Surg. 2026. PMID: 42753882. doi:10.1016/j.athoracsur.2026.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。